Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference41 articles.
1. Current management of pancreatic carcinoma;Lillemoe;Ann Surg,1995
2. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer;Duffy;Mol Cancer,2003
3. Gemcitabine-based combination treatment of pancreatic cancer;Heinemann;Semin Oncol,2002
4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997
5. An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma;Storniolo;Cancer,1999
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in the treatment of pancreatic cancer with traditional Chinese medicine;Frontiers in Pharmacology;2023-08-07
2. Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms;Biomedicine & Pharmacotherapy;2023-06
3. Research Progress and New Perspectives of Anticancer Effects of Emodin;The American Journal of Chinese Medicine;2023-01
4. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review;Cancers;2022-05-18
5. The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers;International Journal of Biological Sciences;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3